|
RALA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21660000021551E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.37149999970931E-07 |
| Normal-vs-Stage2 |
5.043300E-03 |
| Normal-vs-Stage3 |
6.529700E-02 |
| Normal-vs-Stage4 |
4.615700E-03 |
| Stage1-vs-Stage2 |
4.902000E-01 |
| Stage1-vs-Stage3 |
1.682400E-02 |
| Stage1-vs-Stage4 |
9.582200E-01 |
| Stage2-vs-Stage3 |
6.239600E-02 |
| Stage2-vs-Stage4 |
5.779200E-01 |
| Stage3-vs-Stage4 |
1.151810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.1153000007732E-08 |
| Normal-vs-AfricanAmerican |
5.272400E-01 |
| Normal-vs-Asian |
5.078200E-01 |
| Caucasian-vs-AfricanAmerican |
1.936680E-03 |
| Caucasian-vs-Asian |
6.426200E-01 |
| AfricanAmerican-vs-Asian |
5.521000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.83390000022088E-07 |
| Normal-vs-Female |
5.847600E-04 |
| Male-vs-Female |
1.271430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.487630E-02 |
| Normal-vs-Age(41-60Yrs) |
1.31199999997555E-06 |
| Normal-vs-Age(61-80Yrs) |
7.64930000000108E-05 |
| Normal-vs-Age(81-100Yrs) |
9.193600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.016000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.605200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.486500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.379800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.433710E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.810300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.337700E-02 |
| Normal-vs-Grade 2 |
3.79829999674897E-08 |
| Normal-vs-Grade 3 |
1.895840E-02 |
| Normal-vs-Grade 4 |
3.752400E-02 |
| Grade 1-vs-Grade 2 |
4.596800E-01 |
| Grade 1-vs-Grade 3 |
2.383600E-02 |
| Grade 1-vs-Grade 4 |
3.127600E-01 |
| Grade 2-vs-Grade 3 |
7.002400E-04 |
| Grade 2-vs-Grade 4 |
3.349400E-01 |
| Grade 3-vs-Grade 4 |
3.566200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.23039999966323E-07 |
| Normal-vs-ccB subtype |
6.43269999999196E-05 |
| ccA subtype-vs-ccB subtype |
9.889000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.07709999996874E-06 |
| Normal-vs-N1 |
3.767200E-01 |
| N0-vs-N1 |
4.701400E-01 |
|
|
